Hepatitis C Testing Market to Reach $2.6 billion, Globally, by 2035 at 4.9% CAGR: Allied Market Research

Expansion of government screening programs, rise in prevalence of hepatitis c & need for its early detection, and advancements in diagnostic technologies drive the growth of the global hepatitis C testing market.

/EIN News/ -- Wilmington, Delaware, March 20, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Hepatitis C Testing Market by Technique (Immunoassay, PCR, and Other Techniques), Test (Antibody Test, Genotype Tests, and Viral Load Test), and End User (Hospital & Diagnostic Laboratory, Blood Banks, and Other End Users): Global Opportunity Analysis and Industry Forecast, 2024-2035". According to the report, the "hepatitis C testing market" was valued at $1.5 billion in 2023, and is estimated to reach $2.6 billion by 2035, growing at a CAGR of 4.9% from 2024 to 2035. 

Request Sample of the Report on Global Hepatitis C Testing Market 2035 - https://www.alliedmarketresearch.com/request-sample/A17601 

Prime determinants of growth 

Growing hepatitis C prevalence and need for early detection are the factors that drive the growth of the global hepatitis C testing market. However regulatory compliance is anticipated to hinder market growth. On the contrary, a rise in technological advancements is expected to offer remunerative opportunities for the hepatitis C testing market during the forecast period.  

Report coverage & details

Report Coverage	Details
Forecast Period	2024–2035
Base Year	2023
Market Size in 2023	$1.5 billion
Market Size in 2035	$2.6 billion
CAGR	4.9%
No. of Pages in Report	312
Segments covered	Technique, Test, End User, and Region
Regional scope	North America, Europe, Asia Pacific, LAMEA
Drivers	Presence of prevalence of hepatitis C cases     Availability of standard guidelines     Growing adoption of point of care testing
Opportunity	Technological advancements in hepatitis C testing
Restraint	Regulatory challenges and low awareness

Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A17601 

The immunoassay segment held the highest market share in 2023. 

By technique, the immunoassay segment accounted for the largest share in 2023, accounting for almost three-fifths of the global hepatitis C testing market revenue. This dominance is attributed to its cost-effectiveness, ease of use, and high throughput capabilities. It enables rapid screening for HCV antibodies, making it ideal for large-scale screenings in hospitals, blood banks, and point-of-care settings, driving widespread adoption globally.  

However, the PCR test segment is projected to register a highest CAGR of 5.4% during the forecast period. This growth is attributed to its superior sensitivity, accuracy, and ability to detect low viral loads. Surge in adoption of real-time PCR assays for early and confirmatory diagnosis, coupled with advancements in automation and portable PCR platforms, is driving demand for hepatitis C testing solutions. In addition, increase in government initiatives for early screening programs and rise in need for high-throughput diagnostic solutions further support segment expansion.  

The antibody segment held the highest market share in 2023. 

By test, the antibody segment accounted for the largest share in 2023, accounting for almost three-fifths of the global hepatitis C testing market revenue. This is attributed to its cost-effectiveness, widespread availability, and ease of use in initial screening. The high adoption in blood banks, hospitals, and diagnostic centers, along with government-led screening programs, contributed to its growth. Additionally, its rapid turnaround time makes it a preferred choice for large-scale testing.  

However, the viral load test segment is projected to register a highest CAGR of 5.8% during the forecast period. This growth is attributed to its critical role in monitoring treatment response and disease progression. The increasing adoption of quantitative PCR-based assays, advancements in automated molecular diagnostics, and the growing emphasis on personalized treatment strategies are key drivers. Additionally, rising hepatitis C cases and expanded government screening initiatives further boost demand for viral load testing.  

The hospital and diagnostic laboratory segment held the highest market share in 2023. 

By end user, the hospital and diagnostic laboratory segment accounted for the largest share in 2023, accounting for almost three-fifths of the global hepatitis C testing market revenue. This is attributed to the high volume of hepatitis C tests conducted in these settings, ensuring accurate diagnosis and disease monitoring. Advanced laboratory infrastructure, skilled professionals, and access to molecular testing technologies further drive demand. Additionally, government-led screening programs, increasing hospital visits, and the rising prevalence of hepatitis C infections contribute to the segment's strong market presence and growth.  

However, the blood banks segment is projected to register highest CAGR of 5.4% during the forecast period. This growth is attributed to the rising demand for safe blood transfusions and stringent screening regulations to prevent hepatitis C transmission. Increasing blood donation drives, advancements in nucleic acid testing (NAT), and government mandates for infectious disease screening further drive growth. Additionally, the expansion of blood banks in emerging economies supports market expansion.  

North America held the highest market share in 2023. 

By region, North America held the highest market share in terms of revenue in 2023, accounting for almost two-fifths of the global hepatitis C testing market revenue. This is primarily owing to the presence of hepatitis Cases, advanced healthcare infrastructure, and widespread adoption of molecular diagnostics. Supportive government initiatives, strong reimbursement policies, and increased awareness programs further contributed to the region’s market dominance.  

However, the Asia-Pacific segment is projected to register highest CAGR of 5.8%, owing to presence of hepatitis C cases, expanding healthcare infrastructure, and increasing government screening programs. Growing awareness, improving access to advanced diagnostic technologies, and the presence of a large undiagnosed population further drive market growth. Additionally, affordable testing solutions and rising healthcare investments boost adoption.  

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A17601 

Leading Market Players  

• Abbott Laboratories 
• Cosara Diagnostics Pvt Ltd 
• Meril Life Sciences Pvt. Ltd. 
• Molbio Diagnostics Pvt. Ltd. 
• Qiagen N.V. 
• Trivitron Healthcare 
• Bio-Rad Laboratories, Inc. 
• F. Hoffmann-La Roche Ltd. 
• Hologic, Inc. 
• Thermo Fisher Scientific Inc. 

The report provides a detailed analysis of these key players of the global hepatitis C testing market. These players have adopted different strategy such product approval, collaboration, and launch as the key strategies for expansion of their product portfolio to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

Trending Reports in Healthcare Industry:  

Nanomedicine Market - Global Opportunity Analysis and Industry Forecast, 2024-2035 

Personalized Medicine Market - Global Opportunity Analysis and Industry Forecast, 2024-2035 

In Vitro Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2024-2035 

Anti-Obesity Drugs Market - Global Opportunity Analysis and Industry Forecast, 2024-2035 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research: 

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports. 

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access 

About Allied Market Research: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.  

Contact 

David Correa 

1209 Orange Street, 

Corporation Trust Center, 

Wilmington, New Castle, 

Delaware 19801 USA. 

Toll Free: +1-800-792-5285 

Int’l: +1-503-894-6022 

UK: +44-845-528-1300 

Hong Kong: +852-301-84916 

India (Pune): +91-20-66346060 

Fax: +1-855-550-5975 

help@alliedmarketresearch.com   

Web: https://www.alliedmarketresearch.com    

Follow Us on: LinkedIn Twitter